The umbilical cord mesenchymal stem cell‐derived exosomal lncRNA H19 improves osteochondral activity through miR‐29b‐3p/FoxO3 axis. Issue 1 (13th January 2021)
- Record Type:
- Journal Article
- Title:
- The umbilical cord mesenchymal stem cell‐derived exosomal lncRNA H19 improves osteochondral activity through miR‐29b‐3p/FoxO3 axis. Issue 1 (13th January 2021)
- Main Title:
- The umbilical cord mesenchymal stem cell‐derived exosomal lncRNA H19 improves osteochondral activity through miR‐29b‐3p/FoxO3 axis
- Authors:
- Yan, Litao
Liu, Gejun
Wu, Xing - Abstract:
- Abstract: Background: Our previous study revealed that the exosomal lncRNA H19 derived from umbilical cord mesenchymal stem cells (UMSCs) plays a pivotal role in osteochondral regeneration. In this study, we investigated whether the exosomal lncRNA H19 could act as a competing endogenous RNA (ceRNA) to potentiate osteochondral activity in chondrocytes. Methods: Dual‐luciferase reporter assay, RNA pull‐down, RNA immunoprecipitation (RIP), and fluorescence in situ hybridization (FISH) were carried to verify the interaction between miR‐29b‐3p and both lncRNA H19 and the target mRNA FoxO3. Chondrocytes were treated with UMSC‐derived exosomes, which highly expressing lncRNA H19 expression, followed by apoptosis, migration, senescence, and matrix secretion assessments. An in vivo SD rat cartilage defect model was carried out to explore the role and mechanism of lncRNA H19/miR‐29b‐3p. Results: UMSCs were successfully identified, and exosomes were successfully extracted. Exosomes exhibited the ability to transfer lncRNA H19 to chondrocytes. Mechanistically, exosomal lncRNA H19 potentiated osteochondral activity by acting as a competing endogenous sponge of miR‐29b‐3p, and miR‐29b‐3p directly targeted FoxO3. Intra‐articular injection of exosomes overexpressing lncRNA H19 could promote sustained cartilage repair; however, this effect could be undermined by miR‐29b‐3p agomir. Conclusions: Our study revealed a significant role in the development of strategies against cartilage defectsAbstract: Background: Our previous study revealed that the exosomal lncRNA H19 derived from umbilical cord mesenchymal stem cells (UMSCs) plays a pivotal role in osteochondral regeneration. In this study, we investigated whether the exosomal lncRNA H19 could act as a competing endogenous RNA (ceRNA) to potentiate osteochondral activity in chondrocytes. Methods: Dual‐luciferase reporter assay, RNA pull‐down, RNA immunoprecipitation (RIP), and fluorescence in situ hybridization (FISH) were carried to verify the interaction between miR‐29b‐3p and both lncRNA H19 and the target mRNA FoxO3. Chondrocytes were treated with UMSC‐derived exosomes, which highly expressing lncRNA H19 expression, followed by apoptosis, migration, senescence, and matrix secretion assessments. An in vivo SD rat cartilage defect model was carried out to explore the role and mechanism of lncRNA H19/miR‐29b‐3p. Results: UMSCs were successfully identified, and exosomes were successfully extracted. Exosomes exhibited the ability to transfer lncRNA H19 to chondrocytes. Mechanistically, exosomal lncRNA H19 potentiated osteochondral activity by acting as a competing endogenous sponge of miR‐29b‐3p, and miR‐29b‐3p directly targeted FoxO3. Intra‐articular injection of exosomes overexpressing lncRNA H19 could promote sustained cartilage repair; however, this effect could be undermined by miR‐29b‐3p agomir. Conclusions: Our study revealed a significant role in the development of strategies against cartilage defects for UMSC‐derived exosomes that overexpress lncRNA H19. Exosomal H19 was found to promote chondrocyte migration, matrix secretion, apoptosis suppression, as well as senescence suppression, both in vitro and in vivo. The specific mechanism lies in the fact that exosomal H19 acts as a ceRNA against miR‐29b‐3p to upregulate FoxO3 in chondrocytes. Abstract : Exosomes derived from UMSCs exhibited the ability to transfer lncRNA H19 to chondrocytes. Exosomal H19 was found to promote chondrocyte migration, matrix secretion, apoptosis suppression, as well as senescence suppression, both in vitro and in vivo. The specific mechanism lies in the fact that exosomal H19 acts as a ceRNA against miR‐29b‐3p to upregulate FoxO3 in chondrocytes. … (more)
- Is Part Of:
- Clinical and translational medicine. Volume 11:Issue 1(2021)
- Journal:
- Clinical and translational medicine
- Issue:
- Volume 11:Issue 1(2021)
- Issue Display:
- Volume 11, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 11
- Issue:
- 1
- Issue Sort Value:
- 2021-0011-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-01-13
- Subjects:
- chondrocytes -- exosomes -- long noncoding RNA -- umbilical cord mesenchymal stem cells
Clinical medicine -- Periodicals
Medicine, Experimental -- Periodicals
Medical innovations -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
616.027 - Journal URLs:
- https://onlinelibrary.wiley.com/loi/20011326 ↗
http://www.clintransmed.com/content ↗
http://www.biomedcentral.com/journals/#C ↗
http://www.springer.com/gb/ ↗ - DOI:
- 10.1002/ctm2.255 ↗
- Languages:
- English
- ISSNs:
- 2001-1326
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15688.xml